The influence of sex and of chelation therapy on erythrocyte protoporphyrin and urinary delta-aminolevulinic acid in lead-exposed workers.
D000293:Adolescent; D000328:Adult; D000622:Aminolevulinic Acid / Q000652:urine*; D000747:Anemia, Hypochromic / Q000139:chemically induced; D002614:Chelating Agents / Q000627:therapeutic use*; D004492:Edetic Acid / Q000627:therapeutic use; D004781:Environmental Exposure; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006801:Humans; D007501:Iron / Q000097:blood; D007854:Lead / Q000009:adverse effects* / Q000378:metabolism; D007982:Levulinic Acids / Q000652:urine*; D008297:Male; D008875:Middle Aged; D011166:Porphyrins / Q000097:blood*; D011524:Protoporphyrins / Q000097:blood*; D012306:Risk; D012737:Sex Factors
D002614:Chelating Agents; D007982:Levulinic Acids; D011166:Porphyrins; D011524:Protoporphyrins; D007854:Lead; D000622:Aminolevulinic Acid; D004492:Edetic Acid; D007501:Iron